Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effect of TNF-α inhibitor treatment on microRNAs and endothelial function in collagen induced arthritis. | PLoS One | 2022 | 35213638 | PubTator, text mining | PubMed |
| Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis. | J Clin Med | 2022 | 35207184 | PubTator, text mining | PubMed |
| Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. | Cancers (Basel) | 2022 | 35205837 | PubTator, text mining | PubMed |
| Identification of Novel Gene Variants for Autism Spectrum Disorders in the Lebanese Population Using Whole-Exome Sequencing. | Genes (Basel) | 2022 | 35205231 | PubTator, text mining | PubMed |
| Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity. | Biology (Basel) | 2022 | 35205046 | PubTator, text mining | PubMed |
| The Eutopic Endometrium Proteome in Endometriosis Reveals Candidate Markers and Molecular Mechanisms of Physiopathology. | Diagnostics (Basel) | 2022 | 35204508 | PubTator, text mining | PubMed |
| Dynamic Changes in Pentraxin-3 and Neprilysin in ST Segment Elevation Myocardial Infarction. | Biomedicines | 2022 | 35203485 | PubTator, text mining | PubMed |
| Diagnosing pleural effusions using mass spectrometry-based multiplexed targeted proteomics quantitating mid- to high-abundance markers of cancer, infection/inflammation and tuberculosis. | Sci Rep | 2022 | 35197508 | PubTator, text mining | PubMed |
| Menin directs regionalized decidual transformation through epigenetically setting PTX3 to balance FGF and BMP signaling. | Nat Commun | 2022 | 35194044 | PubTator, text mining | PubMed |
| PM2.5 and Serum Metabolome and Insulin Resistance, Potential Mediation by the Gut Microbiome: A Population-Based Panel Study of Older Adults in China. | Environ Health Perspect | 2022 | 35157499 | PubTator, text mining | PubMed |
| Conformational-specific self-assembled peptides as dual-mode, multi-target inhibitors and detectors for different amyloid proteins. | J Mater Chem B | 2022 | 35156675 | PubTator, text mining | PubMed |
| Bone Marrow-Derived Cells and Wound Age Estimation. | Front Med (Lausanne) | 2022 | 35155503 | PubTator, text mining | PubMed |
| SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS. | Front Immunol | 2022 | 35154090 | PubTator, text mining | PubMed |
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study. | BMC Cardiovasc Disord | 2022 | 35152886 | PubTator, text mining | PubMed |
| The Prescription Drug User Fee Act: Much More Than User Fees. | Med Care | 2022 | 35149663 | PubTator, text mining | PubMed |
| Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases. | Immunol Res | 2022 | 35147920 | PubTator, text mining | PubMed |
| IL‑1β‑induced pentraxin 3 inhibits the proliferation, invasion and cell cycle of trophoblasts in preeclampsia and is suppressed by IL‑1β antagonists. | Mol Med Rep | 2022 | 35137920 | PubTator, text mining | PubMed |
| Structural characterization of immune receptor family short pentraxins, C-reactive protein and serum amyloid P component, in primates. | Dev Comp Immunol | 2022 | 35131310 | PubTator, text mining | PubMed |
| Unraveling a rare cause of spinal stenosis: Coexistent AL and ATTR amyloidosis involving the ligamentum flavum. | Surg Neurol Int | 2022 | 35127212 | PubTator, text mining | PubMed |
| White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition. | Acta Neuropathol Commun | 2022 | 35123591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=25